Concordantly, it has been shown in breast and prostate cancer that tumors use TGFβ to drive EMT to escape the primary tumor site and then reverse the process with BMP signaling driving the Mesenchymal-to-Epithelial-Transition (MET) to colonize the distant metastatic site [36]. Here, TGFB1 is linked to prostate cancer.